Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-24-000144
Filing Date
2024-11-13
Accepted
2024-11-13 16:14:37
Documents
1
Period of Report
2024-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1731532469.html 4  
1 FORM 4 wk-form4_1731532469.xml 4 3260
  Complete submission text file 0001439222-24-000144.txt   4804
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Washburn Theodore James Jr. (Reporting) CIK: 0001874199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 241454396